450 related articles for article (PubMed ID: 30887265)
1. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
Shi X; Xu T; Huang W; Fan B; Sheng X
AAPS PharmSciTech; 2019 Mar; 20(4):143. PubMed ID: 30887265
[TBL] [Abstract][Full Text] [Related]
2. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
[TBL] [Abstract][Full Text] [Related]
3. In-Vitro Characterization and Oral Bioavailability of Organic Solvent-free Solid Dispersions Containing Telmisartan.
Cao Y; Shi LL; Cao QR; Yang M; Cui JH
Iran J Pharm Res; 2016; 15(2):385-94. PubMed ID: 27642309
[TBL] [Abstract][Full Text] [Related]
4. Application of Solid Dispersion Technique to Improve Solubility and Sustain Release of Emamectin Benzoate.
Huang BB; Liu DX; Liu K; Wu G
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779169
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
6. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
7. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
Dukeck R; Sieger P; Karmwar P
Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
[TBL] [Abstract][Full Text] [Related]
8. Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability.
Liu P; Zhou JY; Chang JH; Liu XG; Xue HF; Wang RX; Li ZS; Li CS; Wang J; Liu CZ
Drug Des Devel Ther; 2020; 14():2959-2975. PubMed ID: 32801637
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
10. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
[TBL] [Abstract][Full Text] [Related]
11. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
12. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
[TBL] [Abstract][Full Text] [Related]
13. Using Supercritical Fluid Technology (SFT) in Preparation of Tacrolimus Solid Dispersions.
Obaidat RM; Tashtoush BM; Awad AA; Al Bustami RT
AAPS PharmSciTech; 2017 Feb; 18(2):481-493. PubMed ID: 27116202
[TBL] [Abstract][Full Text] [Related]
14. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
15. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
Sethia S; Squillante E
Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
[TBL] [Abstract][Full Text] [Related]
16. Tablet Formulation of a Polymeric Solid Dispersion Containing Amorphous Alkalinized Telmisartan.
Chae JS; Chae BR; Shin DJ; Goo YT; Lee ES; Yoon HY; Kim CH; Choi YW
AAPS PharmSciTech; 2018 Oct; 19(7):2990-2999. PubMed ID: 30043191
[TBL] [Abstract][Full Text] [Related]
17. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
18. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
[TBL] [Abstract][Full Text] [Related]
19. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]